Our goal for The Transmitter is ambitious but clear. We aspire to become an essential resource for neuroscientists at all career stages, and to help them stay current and build connections.

Ivan Oransky is editor-in-chief of The Transmitter, having previously served in editorial leadership roles at outlets including MedscapeReuters Health and Scientific American. He is a distinguished writer-in-residence at New York University’s Arthur L. Carter Journalism Institute, where he teaches medical journalism, and co-founder of Retraction Watch, which reports on scientific retractions.

Education

  • M.D., New York University
  • B.A. in biology, Harvard University

Explore more from The Transmitter

Cell population in brainstem coordinates cough, new study shows

The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.

By Calli McMurray
6 September 2024 | 5 min read
Capitol building
Spectrum Microphone

In updated U.S. autism bill, Congress calls for funding boost, expanded scope

The current Autism CARES Act sunsets in late September.

By Rachel Zamzow
5 September 2024 | 5 min listen
Illustration of ketamine blocking open ion channels in active NMDA receptors, quieting the cells and disrupting downstream signaling involved in depression.

Ketamine targets lateral habenula, setting off cascade of antidepressant effects

The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.

By Olivia Gieger
4 September 2024 | 6 min read